Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 4/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29956054 | 0.98 | ERN1 (0.55) | ERN1TDP1TSHRCYP3A4ALOX15 | |
| Bromide SCHEMBL29952083 | 0.98 | ERN1 (0.55) | ERN1TDP1TSHRCYP3A4ALOX15 | |
| Alcohol SCHEMBL28369215 | 0.89 | ERN1 (0.52) | ERN1TDP1TSHRCYP3A4ALOX15 | |
| SCHEMBL4357334 | 0.83 | TDP1 (0.70) | ERN1TDP1ALDH1A1SMN1; SMN2TP53 | |
| SCHEMBL3208051 | 0.82 | TDP1 (0.61) | ERN1TDP1TSHRCYP3A4ALOX15 | |
| Water SCHEMBL28578537 | 0.81 | TDP1 (0.67) | ERN1TDP1ALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL24630268 | 0.77 | CYP3A4 (0.52) | ERN1TDP1TSHRCYP3A4ALOX15 | |
| SCHEMBL27472917 | 0.77 | ALDH1A1 (0.52) | ERN1TDP1TSHRCYP3A4ALOX15 | |
| SCHEMBL135290 | 0.76 | TDP1 (0.40) | ERN1TDP1TSHRCYP3A4ALOX15 | |
| SCHEMBL9404722 | 0.76 | TDP1 (0.48) | ERN1TDP1TSHRCYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| US-12098132-B2 | Process for preparation of aldehyde scavenger and intermediates | ALDEYRA THERAPEUTICS, INC. (US) | 2024-09-24 | — | — | US | claimed |
| CN-118046642-A | Antioxidant composite fabric and preparation method thereof | 柯乘武 | 2024-05-17 | — | — | CN | claimed |
| CN-115850240-B | Synthesis method of medicine ao Lu Taxi Ni for treating acute myelogenous leukemia | 北京康立生医药技术开发有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-115850240-A | Synthetic method of drug Olutascinonide for treating acute myeloid leukemia | 北京康立生医药技术开发有限公司 | 2023-03-28 | — | — | CN | claimed |
| US-20220089542-A1 | PROCESS FOR PREPARATION OF ALDEHYDE SCAVENGER AND INTERMEDIATES | ALDEYRA THERAPEUTICS, INC. | 2022-03-24 | — | — | US | claimed |
| WO-2020223717-A1 | PROCESS FOR PREPARATION OF ALDEHYDE SCAVENGER AND INTERMEDIATES | ALDEYRA THERAPEUTICS, INC. (US) | 2020-11-05 | — | — | WO | claimed |
| CN-107522766-B | Ursolic acid quinolyl hydrazide derivatives with anti-tumor activity and preparation method and application thereof | 南京林业大学 | 2020-03-27 | — | — | CN | claimed |
| EP-2245132-B1 | ENCAPSULATED BENEFIT AGENT | UNILEVER PLC NO 41424 (GB) | 2017-10-18 | — | — | EP | claimed |
| US-20130190500-A1 | PROCESS TO PREPARE 6-CHLORO-3-AMINO-2-(2-HYDROXYPROPYL)-1-AZANAPHTHALENE | NEURON SYSTEMS, INC. (US) | 2013-07-25 | — | — | US | claimed |
| CN-102015993-B | Encapsulated benefit agent | UNILEVER PLC | 2013-03-27 | — | — | CN | claimed |
| CN-102015993-A | Encapsulated benefit agent | UNILEVER PLC | 2011-04-13 | — | — | CN | claimed |
| EP-2245132-A1 | ENCAPSULATED BENEFIT AGENT | Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House (GB) | 2010-11-03 | — | — | EP | claimed |
| WO-2009103576-A1 | ENCAPSULATED BENEFIT AGENT | UNILEVER PLC (GB) | 2009-08-27 | — | — | WO | claimed |
| US-20260132137-A1 | SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1-[4-(PYRIDIN-2-YLOXY)-CYCLOHEXYL]-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENE AND CRYSTALLINE FORMS THEREOF | HOFFMANN LA ROCHE INC (US) | 2026-05-14 | — | — | US | disclosed |
| CN-121871212-A | Sound-absorbing electromagnetic wave-preventing glass and preparation method thereof | 杭州恩隆科技有限公司 | 2026-04-17 | — | — | CN | disclosed |
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | disclosed |
| US-4981968-A | ENZYME INHIBITORS, ANTITUMOR | RESEARCH TRIANGLE INSTITUTE (US) | 1991-01-01 | — | — | US | disclosed |
| WO-1990003169-A1 | SYNTHESIS OF CAMPTOTHECIN AND ANALOGS THEREOF | RESEARCH TRIANGLE INSTITUTE (US) | 1990-04-05 | — | — | WO | disclosed |
| US-4894456-A | CYCLIZATION, ESTERIFICATION | RESEARCH TRIANGLE INSTITUTE (US) | 1990-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089542-A1 | PROCESS FOR PREPARATION OF ALDEHYDE SCAVENGER AND INTERMEDIATES | ALDH2, AOX1, ALDH1A1 | ERN1 3145/4885TDP1 1562/4885TSHR 2958/4885 |
| US-12098132-B2 | Process for preparation of aldehyde scavenger and intermediates | ALDH2, AOX1, ALDH1A1 | ERN1 3145/4885TDP1 1562/4885TSHR 2958/4885 |
| US-20130190500-A1 | PROCESS TO PREPARE 6-CHLORO-3-AMINO-2-(2-HYDROXYPROPYL)-1-AZANAPHTHALENE | AZI2, DNMT1, TPMT | ERN1 4393/4885TDP1 1661/4885TSHR 3185/4885 |
| US-20260132137-A1 | SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1-[4-(PYRIDIN-2-YLOXY)-CYCLOHEXYL]-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENE AND CRYSTALLINE FORMS THEREOF | YWHAQ, CCT8, CYP2C18 | ERN1 2515/4885TDP1 100/4885TSHR 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.